Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Top Cited Papers
Open Access
- 29 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (9), 622-629
- https://doi.org/10.1093/jnci/djn099
Abstract
The effectiveness of cervical cancer screening programs differs widely in different populations. The reasons for these differences are unclear. Routine and comprehensive audits have been proposed as an ethically required component of screening. We performed a nationwide audit of the effectiveness of the Swedish cervical cancer screening program. We identified all invasive cervical cancer cases that were diagnosed in Sweden from January 1, 1999, through December 31, 2001, and had been reported to the Swedish Cancer Registry (n = 1230 cases). We verified the diagnoses by histopathologic rereview and matched each case subject to five (population-based) age-matched control subjects who were identified from the National Population Register. The Pap smear screening histories for case and control subjects were reviewed for a 6-year period using the National Cervical Cancer Screening Register, which contains data on essentially all relevant cytological and histological diagnoses in Sweden. Odds ratios (ORs), and their 95% confidence intervals (CIs), of cervical cancer according to screening history were calculated in conditional logistic regression models. All statistical tests were two-sided. Women who had not had a Pap smear within the recommended screening interval had higher risk of cervical cancer than women who had been screened (OR = 2.52, 95% CI = 2.19 to 2.91). This risk was similarly increased for all age groups ( Phomogeneity = .96). The risk for nonsquamous cell cervical cancers (OR = 1.59, 95% CI = 1.20 to 2.11) was also increased. Women who had not had a Pap smear within the recommended screening interval had a particularly high risk of advanced cancers (OR = 4.82, 95% CI = 3.61 to 6.44). Among women who had been screened within the recommended interval, those with abnormal Pap smears had a higher risk of cervical cancer than those with normal smears (OR = 7.55, 95% CI = 5.88 to 9.69) and constituted 11.5% of all women with cervical cancer. Nonadherence to screening intervals was the major reason for cervical cancer morbidity. The screening program was equally effective for women of all ages and was also effective against nonsquamous cancers.Keywords
This publication has 36 references indexed in Scilit:
- Incidence Trends of Adenocarcinoma of the Cervix in 13 European CountriesCancer Epidemiology, Biomarkers & Prevention, 2005
- Vaccination against human papillomavirus infection: a new paradigm in cervical cancer controlVaccine, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of ScreeningCancer Epidemiology, Biomarkers & Prevention, 2005
- Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 VaccineJNCI Journal of the National Cancer Institute, 2004
- Assessing the evidence for organised cancer screening programmesEuropean Journal of Cancer, 2003
- The causal relation between human papillomavirus and cervical cancerJournal of Clinical Pathology, 2002
- Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health planCancer, 2000
- Trends in cancer of the cervix uteri in Sweden following cytological screeningBritish Journal of Cancer, 1999
- Clinical impact of quality assurance in an organized cervical screening programActa Obstetricia et Gynecologica Scandinavica, 1999